Latest Selling Leads

.
Date Name/CAS No. Check
04-15 09:56 Relfovetmab
2171034-70-9
04-15 09:56 Glenzocimab
2101829-58-5
04-15 09:56 Ieramilimab
2137049-37-5
04-15 09:56 Cendakimab
2151032-62-9
04-15 09:56 Pozelimab
2096328-94-6
04-15 09:56 Levilimab
2035008-70-7
04-15 09:56 Vofatamab
1312305-12-6
04-15 09:56 Mezagitamab
2227490-52-8
04-15 09:56 Cobolimab
2022215-65-0
04-15 09:56 Naxitamab
1879925-92-4
04-15 09:56 Teclistamab
2119595-80-9
04-15 09:56 Etokimab
2022981-44-6
04-15 09:56 Temelimab
1393641-34-3
04-15 09:56 Gancotamab
1509928-00-0
04-15 09:56 Toripalimab
1924598-82-2
04-15 09:56 Tabituximab
1644134-10-0
04-15 09:56 Talquetamab
2226212-40-2
04-15 09:56 Atogepant
1374248-81-3
04-15 09:56 (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane
119302-24-8
04-15 09:56 (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate
204254-96-6